[Home ] [Archive]    
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: year 14, Issue 58 (3-2023) ::
3 2023, 14(58): 19-23 Back to browse issues page
Hyper eosinophilia associated with myeloid and lymphoid neoplasms
Nahid Nasiri 1, Habibollah Golafshan2
1- Department of Medical Laboratory Sciences, School of Paramedical Sciences, Diagnostic Laboratory Sciences and Technology Research Center, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran
2- Division of Laboratory Hematology and Blood Banking, Department of Medical Laboratory Sciences, School of Paramedical Sciences, Diagnostic Laboratory Sciences and Technology Research Center, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran
Abstract:   (1193 Views)
Eosinophilia in the absence of allergies, asthma, drug reactions, parasitic infections and connective tissue diseases can be eosinophilic clonal disorders, lymphoma or myeloproliferative disorders.
Hypereosinophilia with the persistence of eosinophils ≥1500 /mm³ in blood or more than 20% of eosinophils in the bone marrow may be observed in many reactive or clonal disorders, the result of which is invasion of organs and the secretion of granules and multi-organ failure. For a patient with hypereosinophilia, reactive causes such as allergies, asthma, medications, infections, autoimmune disorders, or solid tissue tumors should be investigated. If reactive causes are not found, primary eosinophilia should be considered.
According to the WHO revision 2016, FISH or RT-PCR for FIPIL1-PDGFRA fusion and cytogenetic and FISH for gene rearrangements on chromosomes 4q12 (PDGFRA), 5q31-33 (PDGFRB), 8p11-12 (FGFR1) and 9P24 (Jak2) are essential.
Chronic eosinophilic leukemia is considered in the presence of ≥1.5 × 109/L absolute eosinophil count. These patients should lack myeloproliferative family genetic markers (such as t (9;22) and Jak2, CARL and CMPL mutations) and also lack myeloid/lymphoid genetic rearrangements associated with eosinophilia (including PDGFRA, PDGFRB and FGFR1).
Keywords: hypereosinophilia, chronic eosinophilic leukemia, PDGFRA, PDGFRB
Full-Text [PDF 1989 kb]   (1004 Downloads)    
Type of Study: Review | Subject: خون شناسی (هماتولوژی)
Received: 2023/03/12 | Accepted: 2023/03/12 | Published: 2023/03/12
Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nasiri N, Golafshan H. Hyper eosinophilia associated with myeloid and lymphoid neoplasms. 3 2023; 14 (58) :19-23
URL: http://labdiagnosis.ir/article-1-525-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
year 14, Issue 58 (3-2023) Back to browse issues page
Laboratory and Diagnosis
Persian site map - English site map - Created in 0.06 seconds with 36 queries by YEKTAWEB 4660